Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision from v3.4.1 to v3.4.2 appears to be a minor site version update with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 is now displayed on the page, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check41 days agoChange DetectedMinor version update: Revision v3.3.4 was added and Revision v3.3.3 was removed. It does not affect the study details or how users interact with the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s Locations section was updated with new investigational sites across multiple countries and with some existing locations removed.SummaryDifference1%

- Check92 days agoChange DetectedPublications section updated: added a sentence clarifying that publications are automatically filled in from PubMed and may or may not be about the study, and removed the previous sentence about automatic creation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page no longer shows the government funding and operating status notice, an administrative change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.